We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Vasogen (MM) | NASDAQ:VSGN | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.264 | 0 | 00:00:00 |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO SECTION 13a-16 OR 15d-16 OF THE
SECURITIES EXCHANGE ACT OF 1934
For the month of October 2009
Commission File Number: 0-29350
VASOGEN INC. |
(Translation of registrant’s name into English) |
|
4 ROBERT SPECK PARKWAY, 15
TH
FLOOR
|
(Address of principal executive offices)
|
Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.
Form 20-F x |
Form 40-F [_] |
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1). ____
Note: Regulation S-T Rule 101(b)(1) only permits the submission in paper of a Form 6-K if submitted solely to provide an attached annual report to security holders.
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ____
Note: Regulation S-T Rule 101(b)(7) only permits the submission in paper of a Form 6-K if submitted to furnish a report or other document that the registrant foreign private issuer must furnish and make public under the laws of the jurisdiction in which the registrant is incorporated, domiciled or legally organized (the registrant's "home country"), or under the rules of the home country exchange on which the registrant's securities are traded, as long as the report or other document is not a press release, is not required to be and has not been distributed to the registrant's security holders, and, if discussing a material event, has already been the subject of a Form 6-K submission or other Commission filing on EDGAR.
Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.
Yes ___________ |
No x |
If “Yes” is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): 82-______ .
EXHIBIT LIST
Exhibit |
|
Title |
|
|
|
99.1 |
|
A Letter of Confirmation, dated September 28, 2009, from CIBC Mellon Trust Company, to each of the securities commission or equivalent authority of Canada's thirteen provinces and territories, stating that the proxy, the notice of meeting/information circular and the letter of transmittal for Vasogen Inc. have been sent to all registered shareholders of Vasogen Inc., as filed with CSA on October 5, 2009 |
|
|
|
|
|
|
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
|
|
VASOGEN INC.
|
|
|
|
By: |
|
|
|
|
Name: Graham Neil
|
EXHIBIT INDEX
Exhibit |
|
Title |
|
|
|
99.1 |
|
A Letter of Confirmation, dated September 28, 2009, from CIBC Mellon Trust Company, to each of the securities commission or equivalent authority of Canada's thirteen provinces and territories, stating that the proxy, the notice of meeting/information circular and the letter of transmittal for Vasogen Inc. have been sent to all registered shareholders of Vasogen Inc., as filed with CSA on October 5, 2009 |
|
|
|
|
|
|
1 Year Vasogen Chart |
1 Month Vasogen Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions